Martha Schreiber

1.1k total citations
15 papers, 881 citations indexed

About

Martha Schreiber is a scholar working on Epidemiology, Genetics and Virology. According to data from OpenAlex, Martha Schreiber has authored 15 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 10 papers in Genetics and 4 papers in Virology. Recurrent topics in Martha Schreiber's work include Virus-based gene therapy research (10 papers), Herpesvirus Infections and Treatments (9 papers) and Poxvirus research and outbreaks (4 papers). Martha Schreiber is often cited by papers focused on Virus-based gene therapy research (10 papers), Herpesvirus Infections and Treatments (9 papers) and Poxvirus research and outbreaks (4 papers). Martha Schreiber collaborates with scholars based in Canada, France and United States. Martha Schreiber's co-authors include Grant McFadden, Joanne Macen, Chris Upton, Lisa M. Sedger, Gurmit Singh, Frank L. Graham, William J. Muller, Krishna Rajarathnam, K. A. Graham and Lynn K. Boshkov and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Oncogene.

In The Last Decade

Martha Schreiber

14 papers receiving 866 citations

Peers

Martha Schreiber
Karim Essani United States
F C Purves United States
Moyra E.M. Campbell United Kingdom
P L Ward United States
M. B. Gardner United States
Jane Parkinson United Kingdom
J W Hartley United States
John M. Lubinski United States
Martha Schreiber
Citations per year, relative to Martha Schreiber Martha Schreiber (= 1×) peers Steven H. Nazarian

Countries citing papers authored by Martha Schreiber

Since Specialization
Citations

This map shows the geographic impact of Martha Schreiber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Schreiber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Schreiber more than expected).

Fields of papers citing papers by Martha Schreiber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha Schreiber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Schreiber. The network helps show where Martha Schreiber may publish in the future.

Co-authorship network of co-authors of Martha Schreiber

This figure shows the co-authorship network connecting the top 25 collaborators of Martha Schreiber. A scholar is included among the top collaborators of Martha Schreiber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha Schreiber. Martha Schreiber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
2.
Ng, Siemon H. S., Ali Azizi, Rebecca J. Malott, et al.. (2014). Preliminary Evaluation of Next-Generation Sequencing Performance Relative to qPCR and In Vitro Cell Culture Tests for Human Cytomegalovirus. PDA Journal of Pharmaceutical Science and Technology. 68(6). 563–571. 6 indexed citations
3.
Birmingham, Cheryl L., et al.. (2013). Detection of Avian Retroviruses in Vaccines by Amplification on DF-1 Cells with Immunostaining and Fluorescent Product-Enhanced Reverse Transcriptase Endpoint Methods. Journal of Clinical Microbiology. 51(5). 1496–1504. 5 indexed citations
4.
Komata, Tadashi, Takao Kanzawa, Hayato Takeuchi, et al.. (2003). Antitumour effect of cyclin-dependent kinase inhibitors (p16INK4A, p18INK4C, p19INK4D, p21WAF1/CIP1 and p27KIP1) on malignant glioma cells. British Journal of Cancer. 88(8). 1277–1280. 58 indexed citations
6.
Schreiber, Martha, Lisa M. Sedger, & Grant McFadden. (1997). Distinct domains of M-T2, the myxoma virus tumor necrosis factor (TNF) receptor homolog, mediate extracellular TNF binding and intracellular apoptosis inhibition. Journal of Virology. 71(3). 2171–2181. 85 indexed citations
7.
McFadden, Grant, Martha Schreiber, & Lisa M. Sedger. (1997). Myxoma T2 protein as a model for poxvirus TNF receptor homologs. Journal of Neuroimmunology. 72(2). 119–126. 16 indexed citations
9.
Schreiber, Martha & Grant McFadden. (1996). Mutational analysis of the ligand-binding domain of M-T2 protein, the tumor necrosis factor receptor homologue of myxoma virus. The Journal of Immunology. 157(10). 4486–4495. 31 indexed citations
10.
Schreiber, Martha, Krishna Rajarathnam, & Grant McFadden. (1996). Myxoma Virus T2 Protein, a Tumor Necrosis Factor (TNF) Receptor Homolog, Is Secreted as a Monomer and Dimer That Each Bind Rabbit TNFα, but the Dimer Is a More Potent TNF Inhibitor. Journal of Biological Chemistry. 271(23). 13333–13341. 63 indexed citations
11.
McFadden, Grant, Kathryn Graham, Kimberly Ellison, et al.. (1995). Interruption of cytokine networks by poxviruses: lessons from myxoma virus. Journal of Leukocyte Biology. 57(5). 731–738. 74 indexed citations
12.
Schreiber, Martha & Grant McFadden. (1994). The Myxoma Virus TNF-Receptor Homologue (T2) Inhibits Tumor Necrosis Factor-α in a Species-Specific Fashion. Virology. 204(2). 692–705. 57 indexed citations
13.
Walker, Virginia K., et al.. (1991). Yolk polypeptide gene expression in culturedDrosophila cells. In Vitro Cellular & Developmental Biology - Animal. 27(2). 121–127. 8 indexed citations
15.
Stuart, David A., Kathryn Graham, Martha Schreiber, Colin Macaulay, & Grant McFadden. (1991). The target DNA sequence for resolution of poxvirus replicative intermediates is an active late promoter. Journal of Virology. 65(1). 61–70. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026